Clinical TrialID 783
Clinical Evaluation of a Mouthwash Containing Malva Sylvestris Extract.
NCT05138484
Periodontal Diseases
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 783
- Evidence Id
- 783
- Core Evidence Id
- 783
- Source Clinical Trial Id
- 765
- Herb2 Clinical Trial Id
- HBCT000765
- Nct Id
- NCT05138484
- Title
- Clinical Evaluation of a Mouthwash Containing Malva Sylvestris Extract.
- Status
- Completed
- Phase
- Phase 3
- Study Result
- No
- Study Condition
- Periodontal Diseases
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: experimental group 10% mouthwash of M. sylvestris extract
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Triple
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 54
- Outcome Measure
- Basic periodontal examination, The mouth is divided into sextants and using a WHO-standardized periodontal probe (Hu-FriedyⓇ), the probing of each tooth is performed in 3 points (mesial, medial and distal) by vestibular and lingual -palatal of each tooth, registering the highest value per sextant, according to the following coding: 0 (healthy tissue), 1 (positive bleeding, absence of periodontal pocket), 2 (presence of tartar, defective fillings, black area of the probe completely visible), 3 (black area of the probe partially visible, periodontal pocket of 3.5 - 5.5 mm), 4 (black area of the probe below the gingival margin, periodontal pocket greater than 5.5 mm)., 7 days|Gingival index, With a WHO-standardized periodontal probe (Hu-FriedyⓇ), the buccal, lingual and interdental papillae marginal gingivae are probed, using a four-point scale from 0 (absence of inflammation) to 3 (severe inflammation), 7 days|Plaque control record, 5 drops of Bacterial Plaque Revealing Solution (Caristop-Revelador DUAL TONE, MAVERⓇ) are applied and the patient is instructed to make movements with the tongue in such a way that it touches all dental surfaces in a time of 15 seconds . The vestibular, lingual and interproximal surfaces of all the teeth are then examined. To calculate the index, add the total number of dental surfaces with bacterial plaque, divide this number by the total number of surfaces present in the mouth and multiply by 100, 7 days
- Sponsor Collaborator
- Aravena, Pedro, DDS, PhD|Universidad Austral de Chile
- Funded By
- OTHER
- Location
- Universidad Austral de Chile, Valdivia, Chile
- Other Id
- ORD 181
- Start Date
- 2017-10-20
- Primary Completion Date
- 2018-12-17
- Completion Date
- 2019-01-14
- First Posted
- 2021-12-01
- Results First Posted
- Last Update Posted
- 2021-12-01
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT05138484
- Title Cn
- Title En
- Clinical Evaluation of a Mouthwash Containing Malva Sylvestris Extract.
- Bilingual Status
- semi_complete